The BCW Index has started the second half of 2006 strongly with a gain of 3.4 percent for the shortened trading week ended Monday. The Nasdaq Biotech Index outpaced the BCW Index, climbing 5.2 percent, while the Nasdaq gained 4.3 percent, and the Dow Jones Industrial Average rose 2.8 percent. Every stock in the Index gained ground for the tracking period, with Stratagene leading the way with a rise of 12.7 percent. Qiagen and Fisher Scientific both rose more than 6 percent for the week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.